NexoBrid License and Supply Agreements (Details) - MediWound Ltd - USD ($) $ in Millions |
1 Months Ended | 12 Months Ended | |
|---|---|---|---|
Feb. 28, 2023 |
May 31, 2019 |
Dec. 31, 2022 |
|
| Related Party Transaction [Line Items] | |||
| Consideration payment for license | $ 17.5 | ||
| Contingent consideration | 7.5 | $ 7.5 | |
| Milestone payments, assumed intangible assets | $ 7.5 | ||
| Purchases of intangible assets | $ 7.5 | ||
| Maximum contingent consideration | 125.0 | ||
| Sales threshold for first milestone | $ 75.0 | ||
| Term of supply agreement | 5 years | ||
| Renewal term of supply agreement | 24 months | ||
| Supply agreement additional term | 10 years | ||
| X | ||||||||||
- Definition The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition License Agreement, Consideration No definition available.
|
| X | ||||||||||
- Definition License Agreement, Contingent Consideration No definition available.
|
| X | ||||||||||
- Definition License Agreement, Contingent Consideration, Maximum No definition available.
|
| X | ||||||||||
- Definition License Agreement, Initial Milestone, Sales No definition available.
|
| X | ||||||||||
- Definition License Agreement, Supply Agreement, Optional Additional Term No definition available.
|
| X | ||||||||||
- Definition License Agreement, Supply Agreement Renewal Term No definition available.
|
| X | ||||||||||
- Definition License Agreement, Supply Agreement Term No definition available.
|
| X | ||||||||||
- Definition License Agreements, Milestone Payments, Assumed Intangible Assets No definition available.
|
| X | ||||||||||
- Details
|